Comparison of Frequency of Use of Optive and Systane - Full Text View

Comparison of Frequency of Use of Optive and Systane

This study has been completed.

Sponsored by:	Innovative Medical
Information provided by:	Innovative Medical
ClinicalTrials.gov Identifier:	NCT00406510

Purpose

The purpose of this study is subjectively compare duration of action between Optive and Systane.

Condition	Intervention	Phase
Dry Eye	Drug: Optive, Systane	Phase IV

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Single Blind, Active Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Males or females > 18 years old
Mild to moderate dry eye symptoms
Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

Current use of topical cyclosporine
Known contraindications to any study medication or ingredients
Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
Ocular surgery within the past 3 months,
Active ocular allergies

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00406510

Locations


United States, California
	Private Practice
	Azusa, California, United States, 91702

Sponsors and Collaborators

Innovative Medical

Investigators


Principal Investigator:	Milton Hom, OD	Private Practice

More Information

Study ID Numbers:	5283
First Received:	November 30, 2006
Last Updated:	May 30, 2007
ClinicalTrials.gov Identifier:	NCT00406510
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on October 20, 2008